| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NRX Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 50,000 | 09 Apr 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NRXP | NRX Pharmaceuticals, Inc. | 09 Apr 2025 | 1 | $0 | 4 | Director | 10 Sep 2025, 15:34 |
| NRXP | NRX Pharmaceuticals, Inc. | 28 Nov 2022 | 5 | +$14,662 | 4 | Director | 29 Nov 2022, 06:00 |
| NRXP | NRX Pharmaceuticals, Inc. | 21 Oct 2022 | 1 | $0 | 4 | Director | 22 Nov 2022, 16:44 |
| NRXP | NRX Pharmaceuticals, Inc. | 24 May 2021 | 5 | $0 | 4 | Director | 10 Jun 2021, 18:46 |
| NRXP | NRX Pharmaceuticals, Inc. | 24 May 2021 | 0 | $0 | 3 | Director | 10 Jun 2021, 18:30 |